The key to healthier weight loss drugs could be found somewhere unexpected: inside a python’s blood. The slithering serpents have an appetite-suppressing compound in their blood that helps them ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of the side effects linked to popular medications like Ozempic. Researchers at ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma. Biotech uses AI for breakthrough discovery, while large pharma scales it to ...

Drug discovery is becoming more personalized, and the methods used to generate therapeutic insights are advancing alongside it. Spatial biology tools let researchers interrogate tissue function, cell ...